Eğitim Bilgileri
2014 - Devam Ediyor
2014 - Devam EdiyorTıpta Yandal Uzmanlık
Hacettepe Üniversitesi, Tıp Fakültesi, İç Hastalıkları Ana Bilim Dalı, Romatoloji Bilim Dalı, Türkiye
2009 - 2013
2009 - 2013Tıpta Uzmanlık
Kayseri Eğitim Ve Araştırma Hastanesi, İç Hastalıkları Kliniği, Türkiye
2002 - 2008
2002 - 2008Yüksek Lisans
Cumhuriyet Üniversitesi, Tıp Fakültesi, Türkiye
Yaptığı Tezler
2012
2012Yüksek Lisans
MEME KANSERLİ HASTALARDA HASTALIKSIZ VE GENEL SAĞKALIM ANALİZİ
Sağlık Bilimleri Üniversitesi, Kayseri Sağlık Uygulama Ve Araştırma Merkezi, Dahili Tıp Bilimleri Bölümü
Yabancı Diller
B1 Orta
B1 Ortaİngilizce
Araştırma Alanları
Tıp
Sağlık Bilimleri
Dahili Tıp Bilimleri
İç Hastalıkları
Akademik Ünvanlar / Görevler
2013 - Devam Ediyor
2013 - Devam EdiyorAraştırma Görevlisi
Hacettepe Üniversitesi, Tıp Fakültesi (İngilizce), Dahili Tıp Bilimleri Bölümü
Makaleler
2025
20251. Predicting extra-musculoskeletal and peripheral manifestations and their role on biologic treatment in patients with axial spondyloarthritis: TReasure experience
Ediboglu E. D., KALYONCU U., SOLMAZ D., YAŞAR BİLGE N. Ş., Yilmaz S., Bes C., et al.
ARCHIVES OF RHEUMATOLOGY
, sa.1, ss.1-14, 2025 (SCI-Expanded, Scopus, TRDizin)
2024
20242. Tocilizumab as a first line biologic agent in rheumatoid arthritis patients with inadequate response to disease-modifying anti-rheumatic drugs: Real life experience from the TReasure Registry
KARADAĞ Ö., Farisogullari B., YAĞIZ B., Erden A., Ademoglu Z., Kimyon G., et al.
Clinical and Experimental Rheumatology
, cilt.42, sa.1, ss.130-137, 2024 (SCI-Expanded, Scopus)
2024
20243. Clinical characteristics and disease course before and after SARS-CoV-2 infection in a large cohort of systemic sclerosis patients
Avanoglu Güler A., ÖZÇİMEN B., Aydoğdu M. S., Sari A., Numune A., TÜZÜN ERSAN N., et al.
Turkish Journal of Medical Sciences
, cilt.54, sa.1, ss.76-85, 2024 (SCI-Expanded, Scopus, TRDizin)
2023
20234. The predictors of paradoxical reactions, especially psoriasis, to biologic therapy—findings from the TReasure database: a 5-year follow-up study
YAĞIZ B., Lermi N., COŞKUN B. N., DALKILIÇ H. E., KİRAZ S., Erden A., et al.
Rheumatology (United Kingdom)
, cilt.62, sa.12, ss.3962-3967, 2023 (SCI-Expanded, Scopus)
2023
20235. Epidemiological characteristics of hepatitis B and C in patients with inflammatory arthritis: Implications from treasure database
Ersözlü E. D., EKİCİ M., COŞKUN B. N., Badak S. Ö., BİLGİN E., KALYONCU U., et al.
Archives of Rheumatology
, cilt.38, sa.3, ss.347-357, 2023 (SCI-Expanded, Scopus, TRDizin)
2023
20236. Long-Term Results of Immunogenicity of Booster Vaccination against SARS-CoV-2 (Hybrid COV-RAPEL TR Study) in Turkiye: A Double-Blind, Randomized, Controlled, Multicenter Phase 2 Clinical Study
Ates I., Batirel A., Aydin M., Karadag F. Y., Erden A., KÜÇÜKŞAHİN O., et al.
Vaccines
, cilt.11, sa.7, 2023 (SCI-Expanded, Scopus)
2023
20237. Clinical and laboratory factors associated with bamboo spine in patients with axial spondyloarthritis: are there clues for bamboo spine?
Atagündüz P., KİRAZ S., Akar S., KÜÇÜKŞAHİN O., Erden A., Aksoy A., et al.
Clinical and Experimental Rheumatology
, cilt.41, sa.3, ss.620-627, 2023 (SCI-Expanded, Scopus)
2023
20238. Mortality in psoriatic arthritis patients, changes over time, and the impact of COVID-19: results from a multicenter Psoriatic Arthritis Registry (PsART-ID)
Erden A., AYAN G., KILIÇ L., Solmaz D., Bakirci S., Kimyon G., et al.
Clinical Rheumatology
, cilt.42, sa.2, ss.385-390, 2023 (SCI-Expanded, Scopus)
2023
20239. Derivation and validation of adult Still Activity Score (SAS)
KALYONCU U., KAŞİFOĞLU T., Omma A., Bes C., Cinar M., EMMUNGİL H., et al.
Joint Bone Spine
, cilt.90, sa.1, 2023 (SCI-Expanded, Scopus)
2023
202310. Pulmonary hypertension in Behçet’s disease: echocardiographic screening and multidisciplinary approach
ARMAĞAN B., OKŞUL M., ŞENER Y. Z., SARI A., ERDEN A., YARDIMCI G. K., et al.
Turkish Journal of Medical Sciences
, cilt.53, sa.2, ss.563-571, 2023 (SCI-Expanded, Scopus, TRDizin)
2023
202311. The impact of antiphospholipid antibodies in Takayasu arteritis
Firat Şentürk E., ERDEN A., SARI A., ARMAĞAN B., KILIÇ L., KALYONCU U., et al.
Turkish Journal of Medical Sciences
, cilt.53, sa.1, ss.199-205, 2023 (SCI-Expanded, Scopus, TRDizin)
2022
202212. Effectiveness and safety of tofacitinib in rheumatoid arthritis-associated interstitial lung disease: TReasure real-life data
KALYONCU U., BİLGİN E., Erden A., Satış H., TUFAN A., Tekgöz E., et al.
Clinical and Experimental Rheumatology
, cilt.40, sa.11, ss.2071-2077, 2022 (SCI-Expanded, Scopus)
2022
202213. Tuberculin skin test before biologic and targeted therapies: does the same rule apply for all?
Ilgen U., KARADAĞ Ö., Emmungil H., KÜÇÜKŞAHİN O., KOCA S. S., Erden A., et al.
RHEUMATOLOGY INTERNATIONAL
, cilt.42, sa.10, ss.1797-1806, 2022 (SCI-Expanded, Scopus)
2022
202214. PARADOXICAL REACTIONS, ESPECIALLY PSORIASIS IN RHEUMATOLOGY PATIENTS RECEIVING BIOLOGIC THERAPY FROM THE TREASURE DATABASE: A 5-YEAR FOLLOW-UP STUDY
Yagiz B., Lermi N., COŞKUN N., DALKILIÇ H. E., Kiraz S., Ertenli A. I., et al.
ANNALS OF THE RHEUMATIC DISEASES
, cilt.81, ss.1513-1514, 2022 (SCI-Expanded, Scopus)
2022
202215. BIOLOGIC DRUG PREFERENCES OF TURKISH RHEUMATOLOGISTS IN SPONDILOARTROPATHY PATIENTS WITH ADVANCED CHRONIC RENAL DISEASE
Mercan R., Tezcan M. E., Yagiz B., Ates A., Kucuksahin O., YAŞAR BİLGE N. Ş., et al.
ANNALS OF THE RHEUMATIC DISEASES
, cilt.81, ss.1509-1510, 2022 (SCI-Expanded, Scopus)
2022
202216. THE DIFFERENCES BETWEEN THE FIRST PREFERRED BIOLOGICAL DMARD AND THE DRUG SURVIVAL IN GERIATRIC AND YOUNGER ADULT POPULATION WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS: TREASURE REAL-LIFE DATA
Gonullu E., Kalyoncu U., Yagiz B., Ates A., Kucuksahin O., YAŞAR BİLGE N. Ş., et al.
ANNALS OF THE RHEUMATIC DISEASES
, cilt.81, ss.1304, 2022 (SCI-Expanded, Scopus)
2022
202217. EPIDEMIOLOGICAL CHARACTERISTICS OF VIRAL HEPATITIS IN PATIENTS WITH RHEUMATIC DISEASES - IMPLICATIONS FROM TREASURE DATABASE
Ersozlu D., Ekici M., COŞKUN N., Badak S. O., Bilgin E., Kalyoncu U., et al.
ANNALS OF THE RHEUMATIC DISEASES
, cilt.81, ss.919-920, 2022 (SCI-Expanded, Scopus)
2022
202218. FACTORS ASSOCIATED WITH HIP INVOLVEMENT AND ITS IMPACT ON TREATMENT DECISION IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS; TREASURE EXPERIENCE
Ediboglu E. D., Kalyoncu U., Solmaz D., KAŞİFOĞLU T., Tekgoz E., Bes C., et al.
ANNALS OF THE RHEUMATIC DISEASES
, cilt.81, ss.812-813, 2022 (SCI-Expanded, Scopus)
2022
202219. Comprehensive assessment and outcomes of patients with chronic periaortitis
Yardimci G. K., Duzgun S. A., Farisogullari B., Bolek E. C., Eldem F. G., Erden A., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.40, sa.4, ss.801-810, 2022 (SCI-Expanded, Scopus)
2022
202220. Physicians' Biological Drug Preference in Patients With Rheumatoid Arthritis and Spondyloarthritis With a History of Malignancy Perspectives From the Treasure Database
Tekgoz E., Colak S., Yardimci K. G., KÜÇÜKŞAHİN O., Cinar M., Yilmaz S., et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
, cilt.28, sa.2, 2022 (SCI-Expanded, Scopus)
2021
202121. Predictors for the risk and severity of post-thrombotic syndrome in vascular Behcet's disease
AKSOY A., Colak S., Yagiz B., COŞKUN B. N., Omma A., YILDIZ Y., et al.
JOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS
, cilt.9, sa.6, ss.1451-1459, 2021 (SCI-Expanded, Scopus)
2021
202122. In the era of disease-modifying antirheumatic drugs, how close are we to treating rheumatoid arthritis without the use of glucocorticoids?
Yagiz B., COŞKUN B. N., PEHLİVAN Y., DALKILIÇ H. E., KİRAZ S., YAZISIZ V., et al.
RHEUMATOLOGY INTERNATIONAL
, cilt.41, sa.11, ss.1915-1924, 2021 (SCI-Expanded, Scopus)
2021
202123. Uveitis-related Factors in Patients With Spondyloarthritis: TReasure Real-Life Results
Bilge N. S. Y., Kalyoncu U., ATAGÜNDÜZ M. P., Dalkilic E., Pehlivan Y., Kucuksahin O., et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY
, cilt.228, ss.58-64, 2021 (SCI-Expanded, Scopus)
2021
202124. Biological and targeted-synthetic disease-modifying anti-rheumatic drugs with concomitant methotrexate or leflunomide in rheumatoid arthritis: real-life TReasure prospective data
Kimyon G., Kalyoncu U., Kiraz S., Bes C., COŞKUN N., Yagiz B., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.39, sa.4, ss.852-858, 2021 (SCI-Expanded, Scopus)
2021
202125. Association of disease characteristics with the temporal sequence of skin and musculoskeletal disease onset in psoriatic arthritis
Tascilar K., Bayindir O., Dogru A., Tinazzi I., Kimyon G., Ozisler C., et al.
BRITISH JOURNAL OF DERMATOLOGY
, cilt.184, ss.1202-1203, 2021 (SCI-Expanded, Scopus)
2021
202126. TRENDS IN THE CHOICE OF FIRST BIOLOGIC AND TARGETED SYNTHETIC DMARD IN RHEUMATOID ARTHRITIS PATIENTS: 20-YEARS JOURNEY OF HURBIO REAL-LIFE REGISTRY
Ertenli A. I., Kalyoncu U., Karadag O., Kilic L., Akdogan A., Dogan I., et al.
ANNALS OF THE RHEUMATIC DISEASES
, cilt.80, ss.1124, 2021 (SCI-Expanded, Scopus)
2021
202127. CHANGES IN THE PRESCRIPTION PATTERNS OF THE SECOND-LINE BIOLOGIC AND TARGETED SYNTHETIC DMARD IN RHEUMATOID ARTHRITIS PATIENTS: 20-YEARS JOURNEY OF HUR-BIO REAL-LIFE REGISTRY
Kiraz S., Kalyoncu U., Karadag O., Kilic L., Akdogan A., Dogan I., et al.
ANNALS OF THE RHEUMATIC DISEASES
, cilt.80, ss.1124-1125, 2021 (SCI-Expanded, Scopus)
2021
202128. PRESCRIPTION PATTERNS OF THE SECOND BIOLOGIC DMARD IN PSORIATIC ARTHRITIS THROUGH THE LAST DECADE: HURBIO-PsA REAL LIFE EXPERIENCE
Kalyoncu U., Karadag O., Kilic L., Akdogan A., Dogan I., Bilgen S. A., et al.
ANNALS OF THE RHEUMATIC DISEASES
, cilt.80, ss.1299, 2021 (SCI-Expanded, Scopus)
2021
202129. TOFACITINIB IN RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: EFFICACY AND SAFETY ANALYSIS FROM TREASURE REAL-LIFE DATA
Kalyoncu U., Bilgin E., Erden A., Satis H., Tufan A., Tekgoz E., et al.
ANNALS OF THE RHEUMATIC DISEASES
, cilt.80, ss.69-70, 2021 (SCI-Expanded, Scopus)
2021
202130. Disease characteristics of psoriatic arthritis patients may differ according to age at psoriasis onset: cross-sectional data from the Psoriatic Arthritis-International Database
Bilgin E., Aydin S. Z., Tinazzi I., Bayindir O., Kimyon G., Ozisler C., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.39, sa.3, ss.532-536, 2021 (SCI-Expanded, Scopus)
2021
202131. QuantiFERON (R)-TB Gold In-Tube test can be used for screening latent tuberculosis before biological treatment in a Bacille Calmette-Guerin (BCG)-vaccinated country: the HUR-BIO single-center real-life results
ŞEYHOĞLU E., UYAROĞLU O. A., ERDEN A., KILIÇ L., KARADAĞ Ö., AKDOĞAN A., et al.
CLINICAL RHEUMATOLOGY
, cilt.40, sa.5, ss.2027-2035, 2021 (SCI-Expanded, Scopus)
2021
202132. PsART-ID inception cohort: clinical characteristics, treatment choices and outcomes of patients with psoriatic arthritis
Ayan G., Aydin S. Z., Kimyon G., Ozisler C., Tinazzi I., DOĞRU A., et al.
RHEUMATOLOGY
, cilt.60, sa.4, ss.1755-1762, 2021 (SCI-Expanded, Scopus)
2021
202133. Imaging modalities used in diagnosis and follow-up of patients with Takayasu's arteritis
Dincer A. B. K., KILIÇ L., ERDEN A., KALYONCU U., HAZIROLAN T., KİRAZ S., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.51, sa.1, ss.224-230, 2021 (SCI-Expanded, Scopus, TRDizin)
2020
202034. Current Smoking Is Increased in Axial Psoriatic Arthritis and Radiographic Sacroiliitis
Solmaz D., KALYONCU U., Tinazzi I., Bakirci S., Bayindir O., DOĞRU A., et al.
JOURNAL OF RHEUMATOLOGY
, cilt.47, sa.9, ss.1354-1358, 2020 (SCI-Expanded, Scopus)
2020
202035. Pregnancy outcomes in partners of male ankylosing spondylitis patients treated with anti-tumour necrosis factor-alpha biologics: real-life results from a single-centre cross-sectional study
UYAROĞLU O. A., ŞEYHOĞLU E., ERDEN A., KILIÇ L., KARADAĞ Ö., AKDOĞAN A., et al.
RHEUMATOLOGY INTERNATIONAL
, cilt.40, sa.9, ss.1501-1507, 2020 (SCI-Expanded, Scopus)
2020
202036. Psoriasis Symptom Inventory (PSI) as a patient-reported outcome in mild psoriasis: Real life data from a large psoriatic arthritis registry
Aydin S. Z., Kimyon G., Ozisler C., TARHAN E. F., Gunal E. K., KÜÇÜK A., et al.
EUROPEAN JOURNAL OF RHEUMATOLOGY
, cilt.7, sa.2, ss.64-67, 2020 (ESCI, TRDizin)
2020
202037. Geoepidemiology and clinical characteristics of neonatal lupus erythematosus: a systematic literature review of individual patients' data
ERDEN A., Fanouriakis A., KILIÇ L., SARI A., ARMAĞAN B., BİLGİN E., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.50, sa.2, ss.281-290, 2020 (SCI-Expanded, Scopus, TRDizin)
2020
202038. Impact of Having Family History of Psoriasis or Psoriatic Arthritis on Psoriatic Disease
Solmaz D., Bakirci S., Kimyon G., Gunal E. K., DOĞRU A., Bayindir O., et al.
ARTHRITIS CARE & RESEARCH
, cilt.72, sa.1, ss.63-68, 2020 (SCI-Expanded, Scopus)
2019
201939. The recommendations of Turkish Society for Rheumatology for pregnancy management in rheumatic diseases and the use of antirheumatic drugs during pregnancy
APRAŞ BİLGEN Ş. Ş., KILIÇ L., ERDEN A., AŞLAR Z., BES C., KARABULUT G., et al.
Ulusal Romatoloji Dergisi
, cilt.11, sa.2, ss.91-104, 2019 (TRDizin)
2019
201940. Tuberculin Skin Test and Quantiferon (R)-TB Gold In-Tube Test for Latent Tuberculosis Before Biologic Treatments: Lower Agreement Rate in Spondyloarthropathies Compared to Rheumatoid Arthritis
Ilgen U., Turan S., EMMUNGİL H., SARI A., ERDEN A., KILIÇ L., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.71, 2019 (SCI-Expanded, Scopus)
2019
201941. Do ANCA-associated vasculitides and IgG4-related disease really overlap or not?
ERDEN A., BÖLEK E. Ç., Yardimci K. G., KILIÇ L., APRAŞ BİLGEN Ş. Ş., KARADAĞ Ö.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
, cilt.22, sa.10, ss.1926-1932, 2019 (SCI-Expanded, Scopus)
2019
201942. Current Smoking Status Increases the Risk of Axial Psoriatic Arthritis: An Explanation to Smoking Paradox
SOLMAZ D., KALYONCU U., Tinazzi I., Bakirci S., Bayindir O., DOĞRU A., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.71, 2019 (SCI-Expanded, Scopus)
2019
201943. Periaortitis and Coronary Arteritis in IgG4-Related Disease: Eastern Mediterranean Experience
YARDIMCI G. K., SARI A., Erden A., BÖLEK E. Ç., Farisogullari B., KILIÇ L., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.71, 2019 (SCI-Expanded, Scopus)
2019
201944. Delay Between the Onset of Psoriasis and Arthritis in PsA Patients from the PsART International Cohort
Tascilar K., Aydin S. Z., AKAR S., AKSU K., Bakirci S., Bayindir O., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.71, 2019 (SCI-Expanded, Scopus)
2019
201945. What are the main barriers to achieve minimal disease activity in psoriatic arthritis in real life?
Bakirci S., Solmaz D., Al Osaimi N., Dalkilic E., Can M., Erden A., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.37, sa.5, ss.808-812, 2019 (SCI-Expanded, Scopus)
2019
201946. Behcet's disease; A rare refractory patient with vena cava superior syndrome treated with infliximab: a case report and review of the literature
Uyaroglu O. A., ERDEN A., KILIÇ L., PEYNİRCİOĞLU B., KARADAĞ Ö., KALYONCU U.
ACTA CLINICA BELGICA
, cilt.74, sa.5, ss.364-369, 2019 (SCI-Expanded, Scopus)
2019
201947. Increased incidence of spondyloarthropathies in patients with Takayasu arteritis: a systematic clinical survey
Esen S. G., ARMAĞAN B., Atas N., UÇAR M., Varan O., ERDEN A., et al.
JOINT BONE SPINE
, cilt.86, sa.4, ss.497-501, 2019 (SCI-Expanded, Scopus)
2019
201948. Successful Treatment of Amyloid A-Type Amyloidosis Due to Behcet Disease With Tocilizumab
İLBAY A., ERDEN A., SARI A., ARMAĞAN B., AKTAŞ B. Y., BÖLEK E. Ç., et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
, cilt.25, sa.4, 2019 (SCI-Expanded, Scopus)
2019
201949. Proposal for a simple algorithm to differentiate adult-onset Still's disease with other fever of unknown origin causes: a longitudinal prospective study
BİLGİN E., Hayran M., Erden A., Armagan B., Sari A., KILIÇ L., et al.
CLINICAL RHEUMATOLOGY
, cilt.38, sa.6, ss.1699-1706, 2019 (SCI-Expanded, Scopus)
2019
201950. Deficiency of adenosine deaminase 2; special focus on central nervous system imaging
Bulut E., ERDEN A., KARADAĞ Ö., Oguz K. K., ÖZEN S.
JOURNAL OF NEURORADIOLOGY
, cilt.46, sa.3, ss.193-198, 2019 (SCI-Expanded, Scopus)
2019
201951. Change in PsAID-12 scores in patients continuing or discontinuing anti-TNF treatments in psoriatic arthritis: results from the HUR-BIO biologic registry
KALYONCU U., KİRAZ S., APRAŞ BİLGEN Ş. Ş., KARADAĞ Ö., AKDOĞAN A., KILIÇ L., et al.
CLINICAL RHEUMATOLOGY
, cilt.38, sa.4, ss.1187-1192, 2019 (SCI-Expanded, Scopus)
2019
201952. Frequency of Behcet's disease among a group of visually impaired adults
UYAROĞLU O. A., ŞEYHOĞLU E., ERDEN A., Vahabov C., BABAOĞLU H., ARMAĞAN B., et al.
IRISH JOURNAL OF MEDICAL SCIENCE
, cilt.188, sa.1, ss.333-336, 2019 (SCI-Expanded, Scopus)
2019
201953. Polyarteritis nodosa: lessons from 25 years of experience
Sonmez H. E., Armagan B., Ayan G., Barut K., Batu E. D., Erden A., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.37, sa.2, 2019 (SCI-Expanded, Scopus)
2019
201954. Abnormal retinal microvasculature found in active rheumatoid arthritis: a different perspective of microvascular health
BABAOĞLU H., BAYTAROĞLU A., TORĞUTALP M., ERDEN A., KADAYIFÇILAR S., KALYONCU U.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.49, sa.1, ss.20-26, 2019 (SCI-Expanded, Scopus, TRDizin)
2019
201955. Capillaroscopic findings in Turkish Takayasu arteritis patients
AKDOĞAN A., ERDEN A., Firat Senturk E., KILIÇ L., SARI A., ARMAĞAN B., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.49, sa.5, ss.1303-1307, 2019 (SCI-Expanded, Scopus, TRDizin)
2018
201856. Rituximab Therapy in Renal Amyloidosis Secondary to Rheumatoid Arthritis
KILIÇ L., ERDEN A., ŞENER Y. Z., ARMAĞAN B., SARI A., KALYONCU U., et al.
BIOMOLECULES
, cilt.8, sa.4, 2018 (SCI-Expanded, Scopus)
2018
201857. Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study
Fanouriakis A., Adamichou C., Koutsoviti S., Panopoulos S., Staveri C., Klagou A., et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM
, cilt.48, sa.3, ss.467-474, 2018 (SCI-Expanded, Scopus)
2018
201858. Axial psoriatic arthritis: the impact of underdiagnosed disease on outcomes in real life
Aydin S. Z., Kucuksahin O., KILIÇ L., DOĞRU A., Bayindir O., Ozisler C., et al.
CLINICAL RHEUMATOLOGY
, cilt.37, sa.12, ss.3443-3448, 2018 (SCI-Expanded, Scopus)
2018
201859. Comparing immunoglobulin A vasculitis (Henoch-Schonlein purpura) in children and adults: a single-centre study from Turkey
Batu E. D., Sari A., Erden A., Sonmez H. E., Armagan B., Kalyoncu U., et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
, cilt.47, sa.6, ss.481-486, 2018 (SCI-Expanded, Scopus)
2018
201860. Is the PET/CT first choice for differential diagnosis of fever of FUO/IUO?
ARMAĞAN B., ERDEN A., BEYDAŞ Ö., SARI A., KILIÇ L., KALYONCU U.
ANNALS OF THE RHEUMATIC DISEASES
, cilt.77, sa.11, 2018 (SCI-Expanded, Scopus)
2018
201861. Multi-Biologic Usage in Rheumatoid Arthritis Is Not Infrequent in the Routine Practice
SARI A., KILIÇ L., ARMAĞAN B., ERDEN A., Yardimci G., AKDOĞAN A., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.70, 2018 (SCI-Expanded, Scopus)
2018
201862. Clinical Features and Disease Course of Neurologic Involvement in Behcet's Disease
BÖLEK E. Ç., SARI A., Agan B. A., ERDEN A., KILIÇ L., KALYONCU U., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.70, 2018 (SCI-Expanded, Scopus)
2018
201863. In early arthritis patients, high HAQ at baseline and DAS28 at three months predict suboptimal outcomes at two years: a retrospective cohort study
Fanouriakis A., Papalopoulos I., Gergianaki I., Spyrou G., Erden A., Rapsomaniki P., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.36, sa.5, ss.806-813, 2018 (SCI-Expanded, Scopus)
2018
201864. Treatment Choices and Response Rates of SAPHO Syndrome: Single Center Case Series
ERDEN A., EKİCİ M., SARI A., ARMAĞAN B., KILIÇ L., APRAŞ BİLGEN Ş. Ş., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.70, 2018 (SCI-Expanded, Scopus)
2018
201865. Effectiveness of a Biopsychosocial Exercise Approach in Rheumatic Diseases
ÜNAL E., ARIN G., KARACA N. B., OFLAZ F. B., ÖZÇADIRCI A., ERDEN A., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.70, 2018 (SCI-Expanded, Scopus)
2018
201866. A rare cause of proximal muscle weakness: immune necrotising myopathy
GÜVEN D. C., ERDEN A., KILIÇ L., ERDEM ÖZDAMAR S., KARADAĞ Ö.
SCOTTISH MEDICAL JOURNAL
, cilt.63, sa.3, ss.82-86, 2018 (SCI-Expanded, Scopus)
2018
201867. Pulmonary hypertension in Takayasu arteritis
SARI A., ŞENER Y. Z., Fira E., ARMAĞAN B., ERDEN A., OKŞUL M., et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
, cilt.21, sa.8, ss.1634-1639, 2018 (SCI-Expanded, Scopus)
2018
201868. Evaluation of Vitamin B12 Deficiency and Associated Factors in Patients With Systemic Sclerosis
Kilic D. T., AKDOĞAN A., KILIÇ L., SARI A., ERDEN A., ARMAĞAN B., et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
, cilt.24, sa.5, ss.250-254, 2018 (SCI-Expanded, Scopus)
2018
201869. Nationwide Experience With Off-Label Use of Interleukin-1 Targeting Treatment in Familial Mediterranean Fever Patients
AKAR S., Cetin P., KALYONCU U., KARADAĞ Ö., Sari I., Cinar M., et al.
ARTHRITIS CARE & RESEARCH
, cilt.70, sa.7, ss.1090-1094, 2018 (SCI-Expanded, Scopus)
2018
201870. Assessment of subclinical atherosclerosis in psoriatic arthritis patients without clinically overt cardiovascular disease or traditional atherosclerosis risk factors
Bilgen S. A., KALYONCU U., Erden A., CANPOLAT U., KILIÇ L., KARADAĞ Ö., et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY
, cilt.46, sa.5, ss.358-365, 2018 (ESCI, Scopus, TRDizin)
2018
201871. Familial Mediterranean fever: new insights into cancer immunoprevention? Comment on the article by Brenner et al
BİLGİN E., Erden A., DİZDAR Ö.
ARTHRITIS & RHEUMATOLOGY
, cilt.70, sa.7, ss.1167, 2018 (SCI-Expanded, Scopus)
2018
201872. Blood group 'A' may have a possible modifier effect on familial Mediterranean fever and blood group '0' may be associated with colchicine resistance
ERDEN A., BATU AKAL E. D., ARMAĞAN B., SÖNMEZ H. E., SARI A., DEMİR S., et al.
BIOMARKERS IN MEDICINE
, cilt.12, sa.6, ss.565-572, 2018 (SCI-Expanded, Scopus)
2018
201873. Some concerns and improvements from Turkey
ÇINAR O. E., ERDEN A., SARI A., ARMAĞAN B., KILIÇ L.
ANNALS OF THE RHEUMATIC DISEASES
, cilt.77, sa.6, 2018 (SCI-Expanded, Scopus)
2018
201874. Aspergillus Pneumonia in a Patient With Adult-Onset Still Disease Successfully Treated With Anakinra
BİLGİN E., ERDEN A., KILIÇ L., SARI A., ARMAĞAN B., KALYONCU U., et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
, cilt.24, sa.3, ss.156-158, 2018 (SCI-Expanded, Scopus)
2018
201875. Starting of biological disease modifying antirheumatic drugs may be postponed in rheumatoid arthritis patients with multimorbidity: Single center real life results
ARMAĞAN B., SARI A., ERDEN A., KILIÇ L., ERDAT E. C., KILIÇKAP S., et al.
MEDICINE
, cilt.97, sa.13, 2018 (SCI-Expanded, Scopus)
2018
201876. Pulmonary aspergillosis after treatment with infliximab in Still's disease and a literature review of Still's disease and pulmonary aspergillosis
ŞEYHOĞLU E., ERDEN A., KILIÇ L., KARADAĞ Ö., ARIKAN AKDAĞLI S., AKDOĞAN A., et al.
EUROPEAN JOURNAL OF RHEUMATOLOGY
, cilt.5, sa.1, ss.75-78, 2018 (ESCI, TRDizin)
2018
201877. Clinical and Laboratory Features of Metformin Intoxication in Suicidal Patients Attending an Intensive Care Unit
Cetinkaya A., Avci D., Erden A., Akca O., Ozer O., Kalan U., et al.
NIGERIAN JOURNAL OF CLINICAL PRACTICE
, cilt.21, sa.2, ss.143-148, 2018 (SCI-Expanded, Scopus)
2018
201878. Which definition should be used to determine colchicine resistance among patients with familial Mediterranean fever?
Erden A., Batu E. D., Sari A., Sonmez H. E., Armagan B., Demir S., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.36, sa.6, 2018 (SCI-Expanded, Scopus)
2018
201879. Pulmonary Hypertension in Behcet's Disease
Armagan B., Oksul M., Sener Y. Z., Sari A., Erden A., Yardimci G. K., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.36, sa.6, 2018 (SCI-Expanded, Scopus)
2018
201880. Increased psoriasis frequency in patients with familial Mediterranean fever
ERDEN A., BATU AKAL E. D., ŞEYHOĞLU E., SARI A., SÖNMEZ H. E., ARMAĞAN B., et al.
UPSALA JOURNAL OF MEDICAL SCIENCES
, cilt.123, sa.1, ss.57-61, 2018 (SCI-Expanded, Scopus)
2017
201781. ANKİLOZAN SPONDİLİTTE EKLEM MOBİLİTESİNİN BİREYLERİN SAĞLIK ALGISINA ETKİSİNİN İNCELENMESİ
ARIN G., KARACA N. B., OFLAZ F. B., ERDEN A., KARADAĞ Ö., GÖKSÜLÜK D., et al.
Journal of Exercise Therapy and Rehabilitation , cilt.4, sa.3, 2017 (Hakemli Dergi)
2017
201782. Rituximab Experience in Patients With Long-standing Systemic Sclerosis-Associated Interstitial Lung Disease: A Series of 14 Patients
SARI A., Guven D., ARMAĞAN B., ERDEN A., KALYONCU U., KARADAĞ Ö., et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
, cilt.23, sa.8, ss.411-415, 2017 (SCI-Expanded, Scopus)
2017
201783. IgG4-related sclerosing disease with mesenteric and retroperitoneal involvement
Yetkin D. I., ONUR M. R., KARADAĞ Ö., Erden A., AKPINAR E., KÖSEMEHMETOĞLU K.
EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE
, cilt.48, sa.4, ss.767-769, 2017 (ESCI, Scopus)
2017
201784. Older Age and Male Gender Are Independent Predictors of Quantiferon Positivity Among Adult Rheumatic Patients in a Tertiary Care Center from a BCG Vaccinated Country: Hur-BIO Single Center Real Life Results
ŞEYHOĞLU E., UYAROĞLU O. A., ERDEN A., KILIÇ L., ARMAĞAN B., SARI A., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.69, 2017 (SCI-Expanded, Scopus)
2017
201785. Blood Group "a" Was Increased in FMF Patients and Blood Group "0" May be Associated with Colchicine Resistance
ERDEN A., BATU AKAL E. D., ARMAĞAN B., SÖNMEZ H. E., SARI A., DEMİR S., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.69, 2017 (SCI-Expanded, Scopus)
2017
201786. A Retrospective Study Comparing the Phenotype and Outcomes of Patients with Polyarteritis Nodosa between UK and Turkish Cohorts
Karadag O., ERDEN A., BİLGİNER Y., Gopaluni S., SARI A., ARMAĞAN B., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.69, 2017 (SCI-Expanded, Scopus)
2017
201787. Starting of Biological Dmards May be Postponed in RA Patients with Multimorbidity: Single Centre Real Life Results
ARMAĞAN B., SARI A., ERDEN A., KILIÇ L., ERDAT E. C., KARADAĞ Ö., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.69, 2017 (SCI-Expanded, Scopus)
2017
201788. Active Disease Is Associated with Dependency in Inflammatory Arthritis
Durmaz H. O., SARI A., ARMAĞAN B., ERDEN A., KILIÇ L., Karadag O., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.69, 2017 (SCI-Expanded, Scopus)
2017
201789. Requirement and Response Rates of Biologic Agents in Polyarteritis Nodosa (PAN)
Karadag O., ARMAĞAN B., ERDEN A., Gopaluni S., SARI A., KİRAZ S., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.69, 2017 (SCI-Expanded, Scopus)
2017
201790. Pregnancy Outcomes in Male Patients Using Anti-Tumor Necrosis Factor Alpha Patients with Inflammatory Arthritis; Hur-BIO Real Life Experiences
UYAROĞLU O. A., ŞEYHOĞLU E., ERDEN A., KILIÇ L., ARMAĞAN B., SARI A., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.69, 2017 (SCI-Expanded, Scopus)
2017
201791. Which Definition Should be Used to Determine Colchicine Resistance in Patients with Familial Mediterranean Fever?
ERDEN A., BATU AKAL E. D., SARI A., SÖNMEZ H. E., ARMAĞAN B., DEMİR S., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.69, 2017 (SCI-Expanded, Scopus)
2017
201792. Patients with Ankylosing Spondylitis Had Better Adalimumab Survival Than Patients with Non-Radiographic Axial Spondyloarthritis
SARI A., ARMAĞAN B., ERDEN A., KILIÇ L., KARADAĞ Ö., AKDOĞAN A., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.69, 2017 (SCI-Expanded, Scopus)
2017
201793. Comparing polyarteritis nodosa in children and adults: a single center study
ERDEN A., BATU AKAL E. D., SÖNMEZ H. E., SARI A., ARMAĞAN B., ARICI Z. S., et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
, cilt.20, sa.8, ss.1016-1022, 2017 (SCI-Expanded, Scopus)
2017
201794. The Psoriatic Arthritis Registry of Turkey: results of a multicentre registry on 1081 patients
KALYONCU U., Bayindir O., Oksuz M. F., DOĞRU A., Kimyon G., Tarhan E. F., et al.
RHEUMATOLOGY
, cilt.56, sa.2, ss.279-286, 2017 (SCI-Expanded, Scopus)
2017
201795. Assessment of the HScore for reactive haemophagocytic syndrome in patients with rheumatic diseases
Batu E. D., Erden A., Seyhoglu E., KILIÇ L., BÜYÜKAŞIK Y., KARADAĞ Ö., et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
, cilt.46, sa.1, ss.44-48, 2017 (SCI-Expanded, Scopus)
2017
201796. Retention Rate of Etanercept in Patients with Rheumatoid Arthritis Is Better Than That of Monoclonal Antibody
ERDEN A., KILIÇ L., KARADAĞ Ö., KİRAZ S., KILIÇKAP S., AKDOĞAN A., et al.
Acta Medica , cilt.48, sa.3, ss.11-17, 2017 (TRDizin)
2017
201797. The clinical features and outcomes of Turkish patients with IgG4-related disease: a single-center experience
KARADAĞ Ö., Erden A., AYHAN E. A., BÖLEK E. Ç., KALYONCU U., ARMAĞAN B., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.47, sa.5, ss.1307-1314, 2017 (SCI-Expanded, Scopus, TRDizin)
2017
201798. RARE OCCUPATIONAL CAUSE OF NASAL SEPTUM PERFORATION: NICKEL EXPOSURE
BÖLEK E. Ç., Erden A., KÜLEKÇİ C., KALYONCU U., KARADAĞ Ö.
INTERNATIONAL JOURNAL OF OCCUPATIONAL MEDICINE AND ENVIRONMENTAL HEALTH
, cilt.30, sa.6, ss.963-967, 2017 (SCI-Expanded, Scopus)
2017
201799. Romatizmalı hastalar için bir yaşam kalitesi ölçeğiningeliştirilmesi: madde havuzunun oluşturulması
ÜNAL E., ARIN G., TÜRKMEN N. B., KİRAZ S., AKDOĞAN A., KALYONCU U., et al.
Journal of Exercise Therapy and Rehabilitation , cilt.4, ss.62-75, 2017 (TRDizin)
2017
2017100. Evaluation of psoriasis patients with a rheumatologic questionnaire efficiently aids in early detection of psoriatic arthritis
Dogan S., Atakan N., Yildirim S. K., KALYONCU U., ERDEN A.
TURKDERM-ARCHIVES OF THE TURKISH DERMATOLOGY AND VENEROLOGY
, cilt.51, sa.3, ss.88-91, 2017 (ESCI, TRDizin)
2016
2016101. A Nationwide Experience with the Off Label Use of Interleukin 1 Targeting Treatment in Familial Mediterranean Fever Patients
AKAR S., Cetin P., KALYONCU U., KARADAĞ Ö., Sari I., Cinar M., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.68, 2016 (SCI-Expanded, Scopus)
2016
2016102. Clinical Features of Takayasu's Arteritis from an Inception Cohort: Early Disease Is Characterized By 'systemic Inflammation'
ALİBAZ ÖNER F., Unal A. U., Onat A. M., Kisacik B., Zengin O., KARADAĞ Ö., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.68, 2016 (SCI-Expanded, Scopus)
2016
2016103. The Characteristic Features of the Patients with Deficiency of Adenosine Deaminase 2 (DADA2)
ERDEN A., BATU AKAL E. D., Taskiran E. Z., SÖNMEZ H. E., SARI A., ARMAĞAN B., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.68, 2016 (SCI-Expanded, Scopus)
2016
2016104. The Reporting of Patient-reported Outcomes in Studies of Patients with Rheumatoid Arthritis: A Systematic Review of 250 Articles
KILIC L., Erden A., Bingham C. O., GOSSEC L., KALYONCU U.
JOURNAL OF RHEUMATOLOGY
, cilt.43, sa.7, ss.1300-1305, 2016 (SCI-Expanded, Scopus)
2016
2016105. Acute Pancreatitis Caused By Mushroom Poisoning: A Report of Two Cases
Karahan S., ERDEN A., Cetinkaya A., Avci D., Ortakoyluoglu A. I., Karagoz H., et al.
JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS
, cilt.4, sa.1, 2016 (ESCI, Scopus)
2015
2015106. Fatigue, Coping, Sleeping Disorders and Productivity Were Still Not Frequently Reported in Rheumatoid Arthritis Trials Published in 2014-2015: A Systematic Literature Review
KILIÇ L., ERDEN A., Gossec L., KALYONCU U.
ARTHRITIS & RHEUMATOLOGY
, cilt.67, 2015 (SCI-Expanded, Scopus)
2015
2015107. Cytomegalovirus (CMV) Infections in Patients with Rheumatic Diseases: Experience of a Referral Center
ŞENER Y. Z., AKTAŞ B. Y., Erden A., KILIÇ L., Armagan B., İNKAYA A. Ç., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.67, 2015 (SCI-Expanded, Scopus)
2015
2015108. Obesity Is Related with Active State in Psoriatic Arthritis and Rheumatoid Arthritis but Not Ankylosing Spondylitis at Real Life Biological Cohort
KALYONCU U., KILIÇ L., ERDEN A., SARI A., ARMAĞAN B., KARADAĞ Ö., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.67, 2015 (SCI-Expanded, Scopus)
2015
2015109. Convergent Construct Validity of PsAID12 in a Psoriatic Arthritis Cohort at Baseline
KALYONCU U., KILIÇ L., ERDEN A., KARADAĞ Ö., APRAŞ BİLGEN Ş. Ş., KİRAZ S., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.67, 2015 (SCI-Expanded, Scopus)
2015
2015110. Fatigue May be Independently Active at a Certain Part of Spondyloarthritis Patients: Hur-BIO Real Life Results
KALYONCU U., Erden A., KILIÇ L., Seyhoglu E., Guven D. C., AKTAŞ B. Y., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.67, 2015 (SCI-Expanded, Scopus)
2015
2015111. FIVE FACTOR SCORE (FFS) AND ITS RELATIONSHIP WITH MORTALITY IN GRANULOMATOUS POLIANGIITIS (GPA)
Karadag O., Kilic L., Erden A., Dogan I., Kalyoncu U., Kilickap S., et al.
ANNALS OF THE RHEUMATIC DISEASES
, cilt.74, ss.523, 2015 (SCI-Expanded, Scopus)
2015
2015112. ASAS PARTIAL REMISSION RATIO OF AS AND AXIAL SPONDYLOARTHRITIS PATIENTS DURING ANTI-TNF TREATMENTS: HUR-BIO REAL LIFE RESULTS
Kalyoncu U., Kilic L., Erden A., Seyhoglu E., Kilickap S., Sener Y. Z., et al.
ANNALS OF THE RHEUMATIC DISEASES
, cilt.74, ss.278, 2015 (SCI-Expanded, Scopus)
2015
2015113. NOT INCREASED CANCER FREQUENCY AT PATIENTS WITH RHEUMATOID ARTHRITIS DURING TNF INHIBITOR TREATMENTS: HUR-BIO REAL LIFE RESULTS
Torgutalp M., Kilickap S., Babaoglu H., Karadag O., Kilic L., Erden A., et al.
ANNALS OF THE RHEUMATIC DISEASES
, cilt.74, ss.1024, 2015 (SCI-Expanded, Scopus)
2015
2015114. SIGNIFICANCE AND TIMING OF IMAGING IN TAKAYASU'S ARTERITIS
Kelesoglu B., Karadag O., Kalyoncu U., Kilic L., Erden A., Akdogan A., et al.
ANNALS OF THE RHEUMATIC DISEASES
, cilt.74, ss.1119-1120, 2015 (SCI-Expanded, Scopus)
2015
2015115. PREVALENCE OF LOW BACK PAIN AND CHRONIC LOW BACK PAIN AND RELATED FACTORS: OUTCOMES OF CAPPADOCIA CHRONIC DISEASES EPIDEMIOLOGICAL STUDY
Kalyoncu U., Akdogan A., Karadag O., Erden A., Kilic L., Bilgen S. A., et al.
ANNALS OF THE RHEUMATIC DISEASES
, cilt.74, ss.1299, 2015 (SCI-Expanded, Scopus)
2015
2015116. COMPARING THE CHARACTERISTICS OF ADULT AND PEDIATRIC PATIENTS WITH POLYARTERITIS NODOSA
Erden A., Balu E. D., Arici Z. S., Bilgin E., Bilgen S. A., Karadagl O., et al.
ANNALS OF THE RHEUMATIC DISEASES
, cilt.74, ss.1113-1114, 2015 (SCI-Expanded, Scopus)
2015
2015117. ASSESSMENT OF THE HSCORE FOR REACTIVE HEMOPHAGOCYTIC SYNDROME IN PATIENTS WITH RHEUMATIC DISEASES
Batu E. D., Erden A., Seyhoglu E., Kilic L., Karadag O., Bilgen S. A., et al.
ANNALS OF THE RHEUMATIC DISEASES
, cilt.74, ss.398, 2015 (SCI-Expanded, Scopus)
2015
2015118. ANTI-TNF ALPHA DRUGS RETENTION RATE AT ANKYLOSING SPONDYLITIS AND AXIAL SPONDYLOARTHRITIS: HUR-BIO REAL LIFE RESULTS
Kalyoncu U., Babaoglu H., Erden A., Kilic L., Torgutalp M., Karadag O., et al.
ANNALS OF THE RHEUMATIC DISEASES
, cilt.74, ss.279-280, 2015 (SCI-Expanded, Scopus)
2015
2015119. PREVALENCE OF RECURRENT APHTHOUS STOMATITIS AND RELATED FACTORS: OUTCOMES OF CAPPADOCIA CHRONIC DISEASES EPIDEMIOLOGICAL STUDY
Kiraz S., Akdogan A., Karadag O., Erden A., Kilic L., Kalyoncu U., et al.
ANNALS OF THE RHEUMATIC DISEASES
, cilt.74, ss.1295, 2015 (SCI-Expanded, Scopus)
2015
2015120. BEHCET DISEASE FREQUENCY AMONG PEOPLE WITH VISUAL LOSS
Uyaroglu O., Erden A., Tatar O., Babaoglu H., Vahabov C., Karadag A., et al.
ANNALS OF THE RHEUMATIC DISEASES
, cilt.74, ss.1116, 2015 (SCI-Expanded, Scopus)
2014
2014121. Etanercept Have Better Drug Survival Than Monoclonal Antibodies in Rheumatoid Arthritis: Results of Single Center Hur-BIO Registry.
KALYONCU U., TORĞUTALP M., BABAOĞLU H., Kilickap S., KİRAZ S., AKDOĞAN A., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.66, 2014 (SCI-Expanded, Scopus)
2014
2014122. Mortality Ratio of Rheumatoid Arthritis Under Biological Treatment.
KALYONCU U., ERDEN A., BABAOĞLU H., TORĞUTALP M., Kilickap S., KARADAĞ Ö., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.66, 2014 (SCI-Expanded, Scopus)
2014
2014123. Impact of perioperative lidocaine infusion and bis monitorization on remifentanil dosage in hypotensive anesthesia
Uzun S., Yuce Y., Erden A., Aypar U.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
, cilt.18, sa.4, ss.559-565, 2014 (SCI-Expanded, Scopus)
2014
2014124. Frequency of Radiological Hip Involvement and Total Hip Replacement in a Large Single Center Spondyloarthritis Cohort with Biological Treatments: HUR-BIO Real Life Results
KALYONCU U., KARADAĞ Ö., KILIÇ L., Ertenli I., ERDEN A., APRAŞ BİLGEN Ş. Ş., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.32, sa.4, 2014 (SCI-Expanded, Scopus)
2014
2014125. Risk Factors of Advanced Spinal Disease and/or Bamboo Disease in Patients with Ankylosing Spondylitis during TNFi Treatments: HUR-BIO Real Life Results
KALYONCU U., KARADAĞ Ö., KILIÇ L., ERDEN A., Ertenli I., APRAŞ BİLGEN Ş. Ş., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.32, sa.4, 2014 (SCI-Expanded, Scopus)
2014
2014126. Evaluation of Systemic Sclerosis Patients by Quantitative Sensory Testing for The Presence of Neuropathy
KILIÇ L., AKDOĞAN A., KARADAĞ Ö., KALYONCU U., ERDEN A., APRAŞ BİLGEN Ş. Ş., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.32, sa.4, 2014 (SCI-Expanded, Scopus)
2014
2014127. Patients with Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis Had Similar TNFi Drug Survival: HUR-BIO Real Life Results
KALYONCU U., KARADAĞ Ö., KILIÇ L., APRAŞ BİLGEN Ş. Ş., ERDEN A., AKDOĞAN A., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.32, sa.4, 2014 (SCI-Expanded, Scopus)
2014
2014128. Retention Rate of TNF-blockers is Greater in Case of Advanced Spinal Ankylosis in Axial Spondyloarthritis: Data from the HUR-BIO Registry
KALYONCU U., KILIÇ L., KARADAĞ Ö., ERDEN A., APRAŞ BİLGEN Ş. Ş., AKDOĞAN A., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.32, sa.4, 2014 (SCI-Expanded, Scopus)
2014
2014129. Patients with Psoriatic Arthritis Had Better TNFi Survival Than Ankylosing Spondylitis: HUR-BIO Real Life Results
KALYONCU U., KARADAĞ Ö., KILIÇ L., APRAŞ BİLGEN Ş. Ş., ERDEN A., AKDOĞAN A., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.32, sa.4, 2014 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2023
20231. THE TRANSITION FROM ACTIVE LESIONS TO STRUCTURAL CHANGES ON SACROILIAC MRI AND ITS ASSOCIATED FACTORS
Kalyoncu U., AYAN G., Kilic L., Atagunduz P., Akar S., YAŞAR BİLGE N. Ş., et al.
European Congress of Rheumatology (EULAR), Milan, İtalya, 31 Mayıs - 03 Haziran 2023, ss.773, (Özet Bildiri)
2023
20232. RADIOGRAPHIC VERSUS NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: RESULTS FROM TREASURE DATABASE
Kilic L., AYAN G., Atagunduz P., Akar S., YAŞAR BİLGE N. Ş., DALKILIÇ H. E., et al.
European Congress of Rheumatology (EULAR), Milan, İtalya, 31 Mayıs - 03 Haziran 2023, ss.1728-1729, (Özet Bildiri)
2023
20233. THE IMPACT OF 6-MONTH DELAY IN DIAGNOSIS ON CLINICAL AND FUNCTIONAL STATUS IN THE PSA PATIENTS UNDER BDMARD TREATMENT: RESULTS FROM TREASURE DATABASE
AYAN G., Kilic L., YAŞAR BİLGE N. Ş., Atagunduz P., DALKILIÇ H. E., PEHLİVAN Y., et al.
European Congress of Rheumatology (EULAR), Milan, İtalya, 31 Mayıs - 03 Haziran 2023, ss.745-746, (Özet Bildiri)
2023
20234. PERFORMANCE OF 2022 ACR/EULAR GPA, EGPA AND MPA CLASSIFICATION CRITERIA IN TURKISH VASCULITIS STUDY GROUP PROSPECTIVE COHORT (TRVAS)
Bolek E. C., AYAN G., BİLGİN E., Ediboglu E. D., Duran E., Kardas C., et al.
European Congress of Rheumatology (EULAR), Milan, İtalya, 31 Mayıs - 03 Haziran 2023, ss.1597-1598, (Özet Bildiri)
2020
20205. PREDICTORS AND SEVERITY OF POST-THROMBOTIC SYNDROME IN VASCULAR BEHCET'S DISEASE: RETROSPECTIVE MULTICENTER STUDY
Aksoy A., Colak S., Yagiz B., Seniz B. N., Omma A., Yildiz Y., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.367-368, (Özet Bildiri)
2019
20196. Psöriatik artrit hastalar›nda 5 yıllık anti-TNF alfa kullanımı sonrasında subklinik aterosklerozun değişimi
ERDEN A., CANPOLAT U., UYAROĞLU O. A., ÇÖTELİ C., KILIÇ L., AKDOĞAN A., et al.
XX. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, cilt.11, ss.233-234, (Özet Bildiri)
2019
20197. IS THERE AN OVERLAP OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIDES WITH IGG4-RELATED DISEASE OR NOT?
ERDEN A., BÖLEK E. Ç., YARDIMCI G. K., APRAŞ BİLGEN Ş. Ş., KARADAĞ Ö.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.990, (Özet Bildiri)
2019
20198. DERIVATION AND VALIDATION OF A NEW STILL ACTIVITY SCORE (SAS)
KALYONCU U., KAŞİFOĞLU T., Omma A., BES C., Cinar M., EMMUNGİL H., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.159-160, (Özet Bildiri)
2019
20199. TRENDS OF SEVERITY, PROGRESSION AND BURDEN OF DISEASE IN THE "ATTIKON" SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) COHORT: EVIDENCE FOR THE RULE OF "ONE THIRD" IN DISEASE SEVERITY
Nikolopoulos D., Pieta A., Kostopoulou M., ERDEN A., Katsimbri P., Boumpas D., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.405, (Özet Bildiri)
2019
201910. UVEITIS RELATED FACTORS IN PATIENTS WITH SPONDYLOARTHRITIS
Bilge N. S. Y., KAŞİFOĞLU T., KİRAZ S., ERTENLİ A. İ., Kucuksahin O., Dalkilic E., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.491, (Özet Bildiri)
2019
201911. SMOKING MAY BE RELATED TO SACROILIITIS IN ENTEROPATHIC ARTHRITIS PATIENTS: TREASURE REAL-LIFE PRELIMINARY DATA
Kucuksahin O., ERDEN A., Ilgen U., KİRAZ S., ERTENLİ A. İ., Bilge N. S. Y., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1824-1825, (Özet Bildiri)
2018
201812. Effectiveness of a Biopsychosocial Exercise Approach in Rheumatic Diseases
ÜNAL E., ARIN G., KARACA N. B., OFLAZ F. B., ÖZÇADIRCI A., ERDEN A., et al.
American College of Rheumatology, ACR Convergence-2018, Chicago, IL, Amerika Birleşik Devletleri, 19 - 24 Ekim 2018, (Tam Metin Bildiri)
2018
201813. Anevrizması olan Behçet hastalar›n tedavisi, prognozu ve mortalitesi
Armagan B., Bolek E. C., SARI A., YARDIMCI G. K., FARİSOĞULLARI B., BİLGİN E., et al.
XIX. Ulusal Romatoloji Kongresi2, Türkiye, 26 - 30 Ekim 2018, (Özet Bildiri)
2018
201814. Evaluation of patients with the diagnosis of vasculitis admitted to a medical ICU
ORTAÇ ERSOY N. E., ÖZEN S., ER B., ÖCAL S., ERDEN A., YARDIMCI G. K., et al.
LIVES, 2018, 20 - 24 Ekim 2018, (Özet Bildiri)
2018
201815. BİLİŞSEL EGZERSİZ TERAPİ YAKLAŞIMI ÖLÇEĞİNİN ROMATOİD ARTRİT TANISI ALAN BİREYLERDE GEÇERLİĞİ, GÜVENİRLİĞİ VE DUYARLILIĞININ BELİRLENMESİ
OFLAZ F. B., KARACA N. B., ÖZÇADIRCI A., ARIN G., KARAKAYA KARABULUT J., ERDEN A., et al.
XIX. Ulusal Romatoloji Kongresi, Türkiye, 26 - 30 Eylül 2018, (Özet Bildiri)
2018
201816. Arteriyel anevrizması olan Behçet hastalarnın klinik özellikleri
Armagan B., Bolek E. C., SARI A., YARDIMCI G. K., FARİSOĞULLARI B., BİLGİN E., et al.
XIX. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 26 - 30 Eylül 2018, cilt.10, ss.68-69, (Özet Bildiri)
2018
201817. FREQUENCY OF PULMONARY HYPERTENSION IN BEHCET'S DISEASE
Armagan B., Oksul M., Sener Y. Z., Sari A., Erden A., Yardimci G. K., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1471, (Özet Bildiri)
2018
201818. ASSOCIATION BETWEEN TISSUE OXYGEN DELIVERY AND DIGITAL ULCERS IN SYSTEMIC SCLEROSIS
Sari A., Sener Y. Z., Oksul M., Armagan B., Erden A., Kilic L., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.743, (Özet Bildiri)
2018
201819. IDIOPATHIC GRANULOMATOUS MASTITIS MAY RESPONSE WELL TO COMBINATION OF IMMUNOSUPRESIVES AND GLUCOCORTICOIDS
Sari A., Konan A., Akpinar M., Armagan B., Erden A., Kilic L., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1152-1153, (Özet Bildiri)
2018
201820. WHICH ONE IS MORE VALUABLE FOR DIAGNOSIS OF ADULT ONSET STILL'S DISEASE? SOLELY NEUTROPHILIA OR LEUKOCYTOSIS WITH NEUTROPHILIA?
Bilgin E., Erden A., Armagan B., Kilic L., Sari A., Yardimci G., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1150, (Özet Bildiri)
2018
201821. FOUR YEARS OF DELAY IN THE DIAGNOSIS OF SAPHO SYNDROME: SINGLE TERTIARY CENTRE EXPERIENCE
Erden A., Ekici M., Armagan B., Sari A., Yardimci G. K., Kilic L., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1552, (Özet Bildiri)
2018
201822. HOW TO DIFFERENTIATE ADULT ONSET STILL'S DISEASE FROM OVERALL OTHER CAUSES OF FEVER OF UNKNOWN ORIGIN: RESULTS OF A PROSPECTIVE STUDY FROM A TERTIARY REFERRAL CENTRE
BİLGİN E., Erden A., Armagan B., KILIÇ L., Sari A., YARDIMCI G. K., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1156-1157, (Özet Bildiri)
2018
201823. PSAID-12 CAN BE USED TO DETERMINE THE ANTI-TNF TREATMENT DECISION IN THE PSORIATIC ARTHRITIS REGISTRY
Kalvoncu U., Kiraz S., Bilgen S. A., Karadag O., Akdogan A., Kilic L., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1601-1602, (Özet Bildiri)
2018
201824. RETENTION RATES OF CERTOLIZUMAB PEGOL IN ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS PATIENTS: HUR-BIO REAL LIFE RESULTS
Armagan B., Sari A., Erden A., Yardimci G. K., Kilic L., Kalyoncu U., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1001-1002, (Özet Bildiri)
2018
201825. COMPARISON OF CUT-OFF VALUES FOR FERRITIN TO DISCRIMINATE ADULT ONSET STILL'S DISEASE FROM OTHER CAUSES OF FEVER OF UNKNOWN ORIGIN: RESULTS OF A PROSPECTIVE STUDY
Bilgin E., Erden A., Armagan B., Kilic L., Sari A., Yardimci G., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1675, (Özet Bildiri)
2018
201826. ANTI-INTERLEUKIN-6 (TOCILIZUMAB) EXPERIENCE IN TAKAYASU'S ARTERITIS PATIENTS
Kilic L., Karadag O., Erden A., Sari A., Armagan B., Firat E., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.437-438, (Özet Bildiri)
2018
201827. POLYARTERITIS NODOSA: OVER 20 YEARS' CLINICAL EXPERIENCE
Sonmez H. E., Armagan B., Ayan G., BARUT K., Batu E. D., Erden A., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.775-776, (Özet Bildiri)
2018
201828. İDİYOPATİK İNTERSTİSYEL PNÖMONİDE KLİNİK ve RADYOLOJİK ÖZELLİKLERİN MULTİDİSİPLİNER DEĞERLENDİRİLMESİ
ER B., ARIYÜREK O. M., ÖZDEN SERTÇELİK Ü., SARI A., AKDOĞAN A., ERDEN A., et al.
Pulmoner Vasküler ve İnterstisyel Akciğer Hastalıklarında Güncel Gelişmeler Sempozyumu, Türkiye, 12 - 14 Ocak 2018, (Özet Bildiri)
2017
201729. A Retrospective Study Comparing the Phenotype and Outcomes of Patients with Polyarteritis Nodosa between UK and Turkish Cohorts
KARADAĞ Ö., ERDEN A., BİLGİNER Y., GOPALUNI S., SARI A., ARMAĞAN B., et al.
2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)
2017
201730. Older Age and Male Gender Are Independent Predictors of Quantiferon Positivity Among Adult Rheumatic Patients in a Tertiary Care Center from a BCG Vaccinated Country: Hur-BIO Single Center Real Life Results
ŞEYHOĞLU E., UYAROĞLU O. A., ERDEN A., KILIÇ L., ARMAĞAN B., SARI A., et al.
2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)
2017
201731. Which Definition Should be Used to Determine Colchicine Resistance in Patients with Familial Mediterranean Fever?
ERDEN A., BATU E. D., SARI A., SÖNMEZ H. E., ARMAĞAN B., FIRAT E., et al.
2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)
2017
201732. Starting of Biological Dmards May be Postponed in RA Patients with Multimorbidity: Single Centre Real Life Results
ARMAĞAN B., SARI A., ERDEN A., KILIÇ L., ERDAT E. C., KARADAĞ Ö., et al.
2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)
2017
201733. Pregnancy Outcomes in Male Patients Using Anti-Tumor Necrosis Factor Alpha Patients with Inflammatory Arthritis Hur-BIO Real Life Experiences
UYAROĞLU O. A., ŞEYHOĞLU E., ERDEN A., KILIÇ L., ARMAĞAN B., SARI A., et al.
2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)
2017
201734. Patients with Ankylosing Spondylitis Had Better Adalimumab Survival Than Patients with Non-Radiographic Axial Spondyloarthritis
SARI A., ARMAĞAN B., ERDEN A., KILIÇ L., KARADAĞ Ö., AKDOĞAN A., et al.
2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)
2017
201735. Blood Group ”a” Was Increased in FMF Patients and Blood Group ”0” May be Associated with Colchicine Resistance
ERDEN A., BATU E. D., ARMAĞAN B., SÖNMEZ H. E., SARI A., DEMİR S., et al.
ARTHRITIS RHEUMATOLOGY, 19 - 24 Ekim 2017, (Tam Metin Bildiri)
2017
201736. PS 121- BAŞ BOYUN TÜMÖRÜNÜ TAKLİT EDEN WEGENER GRANÜLOMATOZ OLGUSU
DURMAZ H., ARMAĞAN B., SARI A., ERDEN A., AKDOĞAN A., ÖZTÜRK H.
19. Ulusal İç Hastalıkları Kongresi, Antalya, Türkiye, 11 - 15 Ekim 2017, (Özet Bildiri)
2017
201737. Sjögren Sendromu’nun Kas Güçsüzlüğü ile Prezantasyonu: Renal Tubuler Asidoz Tip 1
BÖLEK E. Ç., ERDEN A., KOÇ H., KARADAĞ Ö., KALYONCU U., KİRAZ S., et al.
19.Ulusal İç Hastalıkları Kongresi, Türkiye, 11 - 15 Ekim 2017, (Tam Metin Bildiri)
2017
201738. Distribution of vasculitides in Eastern mediteranean: Results of a prospective cohort
KARADAĞ Ö., ERDEN A., BATU E. D., BİLGİN E., UYAROGLU o., ŞEYHOĞLU E., et al.
EUROPEAN LEAGUE AGAİNST RHEUMATOLOGY ANNUAL MEETİNG 2017, 14 - 17 Haziran 2017, (Tam Metin Bildiri)
2017
201739. A Section of Rare Diseases in Hacettepe Adult Clinics in Rheumatology: Deficiency of Adenosine Deaminase 2 (DADA2)
BÖLEK E. Ç., ERDEN A., ÖZEN S., KARADAĞ Ö., KALYONCU U., BATU E. D., et al.
5th Rare Diseases Summer School, 7 - 09 Haziran 2017, (Tam Metin Bildiri)
2017
201740. . IGG4-RELATED DISEASE IN EASTERN MEDITERRANEAN: CLINICAL FEATURES AND OUTCOMES OF A LARGE COHORT
KARADAĞ Ö., ERDEN A., AYHAN E. A., BÖLEK E. Ç., ARMAĞAN B., KILIÇ L., et al.
EULAR 2017, 6 - 10 Haziran 2017, cilt.76, ss.720, (Özet Bildiri)
2017
201741. THORAX CT FINDINGS IN A LARGE COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS: HUR-BIO REAL LIFE RESULTS
Sari A., Armagan B., Erden A., Kilic L., Karadag O., Akdogan A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.256, (Özet Bildiri)
2017
201742. BIOLOGICAL THERAPY IN NON-SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS PATIENTS FOLLOWED IN ADULT RHEUMATOLOGY DEPARTMENT: HUR-BIO REAL LIFE RESULTS
Kilic L., Sari A., Armagan B., Erden A., Karadag O., Akdogan A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.402, (Özet Bildiri)
2017
201743. ABATACEPT EXPERIENCE IN BIOLOGIC NAIVE RHEUMATOID ARTHRITIS PATIENTS: HUR-BIO REAL LIFE RESULTS
Sari A., Armagan B., Kilic L., Erden A., Karadag O., Akdogan A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.854-855, (Özet Bildiri)
2017
201744. PSORIASIS IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER
Erden A., Batu E. D., Bilgin E., Sonmez H. E., Seyhoglu E., Demir S., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.414, (Özet Bildiri)
2017
201745. ADHERENCE OF RHEUMATIC PATIENTS TO INH PROPHYLAXIS PRESCRIBED BEFORE BIOLOGICAL TREATMENT: HUR-BIO SINGLE CENTER REAL LIFE RESULTS
Seyhoglu E., Uyaroglu O. A., Erden A., Kilic L., Armagan B., Sari A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1035, (Özet Bildiri)
2017
201746. REAL-LIFE EXPERIENCE WITH BELIMUMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): CONTROL OF DISEASE ACTIVITY AND FLARES IN A MULTICENTER COHORT
Fanouriakis A., Adamichou C., Koulsoviti S., Klagou A., Tsalapaki C., Konsta S., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1204-1205, (Özet Bildiri)
2017
201747. RESULTS OF SCREENING FOR VIRAL HEPATITIS IN RA PATIENTS TREATED WITH BIOLOGICS: HUR-BIO REAL LIFE RESULTS
Sari A., Armagan B., Erden A., Kilic L., Akdogan A., Bilgen S. A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1175, (Özet Bildiri)
2017
201748. COMORBIDITY AND SURGERY HISTORY OF RHEUMATOID ARTHRITIS PATIENTS WHO ARE RECEIVING BIOLOGICAL AGENT
Armagan B., Sari A., Erden A., Kilic L., Erdat E. C., Karadag O., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.534, (Özet Bildiri)
2017
201749. WIDE HETEROGENEITY IN TREATMENT PROTOCOLS AND INAPPROPIATE USE OF PREDNISOLONE FOR ANTI-RO/LA ASSOCIATED-CONGENITAL HEART BLOCK: A SYSTEMATIC REVIEW OF 492 CASES
Erden A., Kilic L., Bilgin E., Fanouriakis A., Ceylan S., Hyrnabaccus B., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1215-1216, (Özet Bildiri)
2017
201750. BUDD-CHIARI SYNDROME IN BEHCET'S DISEASE: A RETROSPECTIVE MULTICENTER STUDY
Akyol L., Toz B., Bayindir O., Zengin O., Cansu D. U., Yigit M., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.327-328, (Özet Bildiri)
2017
201751. "IF IT'S NOT MULTIPLE SCLEROSIS, LOOK FOR A CONNECTIVE TISSUE DISEASE": ATYPICAL DEMYELINATING DISORDERS REFERRED TO A TERTIARY RHEUMATOLOGY CENTRE
Fanouriakis A., Voumvourakis K., Papathanasiou M., Doskas T., Karageorgas T., Tseronis D., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.588, (Özet Bildiri)
2017
201752. EVALUATION OF VITAMIN B12 DEFICIENCY AND ASSOCIATED FACTORS IN PATIENTS WITH SYSTEMIC SCLEROSIS
Kilic D. T., Sari A., Armagan B., Erden A., Kilic L., Kilinckaya M., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.637-638, (Özet Bildiri)
2017
201753. FUNCTIONAL DISABILITY IN RA PATIENTS TREATED WITH BIOLOGICS: HUR-BIO REAL LIFE RESULTS
Sari A., Armagan B., Erden A., Kilic L., Karadag O., Akdogan A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1127, (Özet Bildiri)
2017
201754. DISTRIBUTION OF VASCULITIDES IN EASTERN MEDITERRANEAN: RESULTS OF A PROSPECTIVE COHORT
Karadag O., Erden A., Batu E. D., Bilgin E., Uyaroglu A. O., Seyhoglu E., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.616, (Özet Bildiri)
2017
201755. ANKYLOSING SPONDYLITIS PATIENTS WITH UVEITIS HAD BETTER ADALIMUMAB RETENTION RATE: HUR-BIO REAL LIFE RESULTS
Armagan B., Sari A., Erden A., Kilic L., Guven D. C., Pashayev T., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1300-1301, (Özet Bildiri)
2017
201756. RAID COMPOSITE INDEX IN THE EVALUATION OF RA PATIENTS RECEIVING BIOLOGICAL TREATMENT: HUR-BIO REAL-LIFE RESULTS
Erden A., Kilic L., Armagan B., Sari A., Akdogan A., Bilgen S. A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1113, (Özet Bildiri)
2017
201757. ARE THE DEMOGRAPHIC AND CLINICAL FEATURES OF POLYARTERITIS NODOSA SIMILAR BETWEEN THE UK AND TURKEY?
Karadag O., Erden A., Batu E. D., Gopaluni S., Sari A., Armagan B., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.329, (Özet Bildiri)
2017
201758. PREMATURE CORONARY HEART DISEASE FREQUENCY IN RHEUMATOID ARTHRITIS WHO ARE RECEIVING BIOLOGIC AGENTS: HUR-BIO REAL LIFE RESULTS
Armagan B., Sari A., Erden A., Kilic L., Erdat E. C., Karadag O., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.250-251, (Özet Bildiri)
2017
201759. THE USE OF RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: IN WHICH INFUSION INTERVALS WERE GIVEN AND HOW DID THEY RESPOND? HUR-BIO REAL LIFE RESULTS
Armagan B., Sari A., Erden A., Kilic L., Karadag O., Akdogan A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1194-1195, (Özet Bildiri)
2017
201760. QUANTIFERON (R)-TB GOLD IN-TUBE ASSAY CAN BE USED FOR LATENT TUBERCULOSIS SCREENING BEFORE BIOLOGICAL DRUG TREATMENT IN A BCG VACCINATED COUNTRY: HUR-BIO SINGLE CENTER REAL LIFE RESULTS
Seyhoglu E., Uyaroglu O. A., Erden A., Kilic L., Armagan B., Sari A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1412-1413, (Özet Bildiri)
2017
201761. PRESENTATION OF A NEW SCALE ASSESSING THE BIOPSYCHOSOCIAL ASPECTS OF HEALING PROPERTIES IN RHEUMATIC PATIENTS
ÜNAL E., KISACIK P., Arin G., KARABULUT E., GÖKSÜLÜK D., Yagli N. V., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1531, (Özet Bildiri)
2017
201762. THERE IS A COMMUNICATION PROBLEM BETWEEN PATIENT AND PHYSICIAN DURING PRE-CONCEPTIONAL PERIOD: HUR-BIO REAL LIFE RESULTS
Uyaroglu O. A., Seyhoglu E., Erden A., Kilic L., Armagan B., Sari A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.448, (Özet Bildiri)
2017
201763. RITUXIMAB EXPERIENCE IN PATIENTS WITH LONGSTANDING SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: A SERIES OF 14 PATIENTS
Sari A., Guven D., Armagan B., Kilic L., Erden A., Akdogan A.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1262-1263, (Özet Bildiri)
2017
201764. Comorbidity and Surgery History of Rheumatoid Arthritis Patients Who Receiving Biological Agent
ARMAĞAN B., SARI A., ERDEN A., KILIÇ L., KARADAĞ Ö., AKDOĞAN A., et al.
MIRCIM 2017 TIHUD-TIP JOINT MEETING, Krakow, Polonya, 11 - 14 Mayıs 2017, (Özet Bildiri)
2017
201765. EVALUATION OF ASSSOCIATION BETWEEN ANTIPHOSPHOLIPID ANTIBODIES OR LUPUS ANTICOAGULANT POSITIVITY AND SEVERITY OF VASCULAR INVOLVEMENT IN TAKAYASU ARTERITIS PATIENTS
FIRAT E., ERDEN A., SARI A., ARMAĞAN B., KILIÇ L., KALYONCU U., et al.
18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.48, (Özet Bildiri)
2017
201766. TWO-YEAR RESULTS OF A PROSPECTIVE VASCULITIS COHORT FROM EASTERN MEDITERRANEAN: DEMOGRAPHIC CHARACTERISTICS AND DISTRIBUTION OF THE VASCULITIDES FREQUENCIES
KARADAĞ Ö., APRAŞ BİLGEN Ş. Ş., ARMAĞAN B., SARI A., ERDEN A., BATU AKAL E. D., et al.
18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, (Özet Bildiri)
2017
201767. SUCCESSFUL TREATMENT OF AORTOENTERIC FISTULA A PATIENT WITH BEHCET DISEASE INTERFERON ALFA2A AND SURGERY
ARMAĞAN B., SARI A., ERDEN A., KILIÇ L., KALYONCU U., KARADAĞ Ö.
18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.94, (Özet Bildiri)
2017
201768. LEUKOCYTOCLASTIC VASCULITIS IN THE BONE MARROW
SARI A., ARMAĞAN B., ERDEN A., KILIÇ L., Ayhan A. S., KARADAĞ Ö.
18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.72, (Özet Bildiri)
2016
201669. DEMOGRAPHIC, CLINIC AND LABORATORY FEATURES OF 755 PATIENTS WITH NEONATAL LUPUS ERYTHEMATOSUS: SYSTEMATIC REVIEW
Erden A., Kilic L., Bilgin E., Ceylan S., Hymabaccus B., Sener Y. Z., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.874, (Özet Bildiri)
2016
201670. DEMOGRAPHIC CHARACTERISTICS AND DISTRIBUTION OF THE VASCULITIDES FREQUENCIES: A REAL-LIFE EXPERIENCE OF VASCULITIS CENTER FROM EASTERN MEDITERRANEAN
Karadag O., Erden A., Bilgin E., Batu E. D., Armagan B., Sari A., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.1096-1097, (Özet Bildiri)
2016
201671. THE CLINICAL AND DEMOGRAPHIC FEATURES OF RELAPSING POLYCHONDRITIS: A NATIONWIDE STUDY
Emmungil H., Erden A., Kucuksahin O., Zengin O., Ermurat S., Gok K., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.569-570, (Özet Bildiri)
2016
201672. RITUXIMAB SEEMS OUTSTANDING BIOLOGICAL OPTION IN LATE ONSET RHEUMATOID ARTHRITIS: HUR-BIO REAL LIFE RESULTS
Kilic L., Erden A., Sari A., Armagan B., Karadag O., Akdogan A., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.1022-1023, (Özet Bildiri)
2016
201673. OPHTALMOLOGIC FINDINGS IN PATIENTS WITH TAKAYASU'S ARTERITIS
Kelesoglu A. B., Baytaroglu A., Sari A., Erden A., Kilic L., Tatar O., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, ss.1101-1102, (Özet Bildiri)
2016
201674. ABNORMAL CENTRAL RETINAL VEIN EQUIVALENT FOUND IN ACTIVE RHEUMATOID ARTHRITIS: A DIFFERENT PERSPECTIVE OF MICROVASCULAR HEALTH
Babaoglu H., Kadayifcilar S., Erden A., Baytaroglu A., Kalyoncu U.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, ss.1000-1001, (Özet Bildiri)
2016
201675. COMPARING THE CHARACTERISTICS OF ADULT AND PEDIATRIC PATIENTS WITH POLYARTERITIS NODOSA
Erden A., Batu E. D., Bilgin E., Sonmez H. E., Armagan B., Sari A., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.799, (Özet Bildiri)
2016
201676. DAPSA WITH TWENTY-EIGHT JOINT COUNTS MAY BE USEFUL FOR THE ASSESSMENT OF PSORIATIC ARTHRITIS
Kalyoncu U., Erden A., Kilic L., Sari A., Armagan B., Karadag O., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.1159-1160, (Özet Bildiri)
2016
201677. COMMON AND UNCOMMON MANIFESTATIONS OF GRANULOMATOSIS WITH POLIANGIITIS (GPA) AT CHEST CT: A VASCULITIS CENTER EXPERIENCE
Taydas O., Kilic L., Atceken Z., Erden A., Armagan B., Sari A., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.796, (Özet Bildiri)
2015
201578. THE RHEUMATOLOGIST'S PERSPECTIVE IN DIAGNOSTIC COURSE AND MANAGEMENT OF FAMILIAL MEDITERRANEAN FEVER
Karadag O., Kilic L., Erden A., Kasifoglu T., Karaaslan Y., Kiraz S., et al.
18th ISPOR Annual European Congress, Milan, İtalya, 7 - 11 Kasım 2015, cilt.18, (Özet Bildiri)
2015
201579. Adrenal insufficiency due to antiphospholipid syndrome in a patient with MTHFR
ŞENER Y. Z., ÖZIŞIK L., ERDEN A., KALYONCU U., DURUSU TANRIÖVER M., BÜYÜKAŞIK Y., et al.
14 th Congress European Federation of Internal Medicine, Moskva, Rusya, 14 - 16 Ekim 2015, ss.328-329
Desteklenen Projeler
2018 - 2020
2018 - 2020Artritli Bireylerin Aktivite Performansı Toplumsal Katılımları ve Aktivite Profillerinin İncelenmesi
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
AKYÜREK G. (Yürütücü), KALYONCU U., ERDEN A., ÜNAL B., GÖKMEN D., Önal G., et al.
2017 - 2017
2017 - 20175 Nadir Hastalıklar Yaz Okulu (5th Rare Diseases Summer School) Katılımı
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
KALYONCU U. (Yürütücü), BÖLEK E. Ç., ERDEN A., ÖZEN S.
2016 - 2017
2016 - 2017